262 related articles for article (PubMed ID: 37634640)
1. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
Kim M; Lee SM; Son IT; Park T; Oh BY
Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Kim DW; Ahn H; Kim KW; Lee SS; Kim HJ; Ko Y; Park T; Lee J
Korean J Radiol; 2022 Nov; 23(11):1055-1066. PubMed ID: 36098341
[TBL] [Abstract][Full Text] [Related]
3. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
4. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
5. Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.
Han Q; Kim SI; Yoon SH; Kim TM; Kang HC; Kim HJ; Cho JY; Kim JW
Front Oncol; 2021; 11():741071. PubMed ID: 34631578
[TBL] [Abstract][Full Text] [Related]
6. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
7. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
[TBL] [Abstract][Full Text] [Related]
8. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
9. Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
Yamashita S; Iguchi T; Koike H; Wakamiya T; Kikkawa K; Kohjimoto Y; Hara I
Int J Urol; 2021 Jul; 28(7):757-762. PubMed ID: 33821510
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer.
Cárcamo L; Peñailillo E; Bellolio F; Miguieles R; Urrejola G; Zúñiga A; Molina ME; Larach JT
ANZ J Surg; 2021 May; 91(5):E298-E306. PubMed ID: 33682291
[TBL] [Abstract][Full Text] [Related]
11. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
[TBL] [Abstract][Full Text] [Related]
12. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
[TBL] [Abstract][Full Text] [Related]
14. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor.
Deng GM; Song HB; Du ZZ; Xue YW; Song HJ; Li YZ
World J Gastroenterol; 2024 Feb; 30(8):863-880. PubMed ID: 38516238
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost.
Findlay M; Brown C; De Abreu Lourenço R; White K; Bauer J
J Hum Nutr Diet; 2020 Dec; 33(6):811-821. PubMed ID: 32609428
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
19. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
[No Abstract] [Full Text] [Related]
20. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
